Vitafoods Asia is the premier exhibition representing the health functional food and nutraceutical industries in the Asia-Pacific region.
The 2026 event will be held from September 2 to 4 at the Queen Sirikit National Convention Center (QSNCC) in Bangkok, Thailand, bringing together functional raw materials and ingredients companies, health functional food brands, OEM/ODM providers, distributors, and industry experts.
Key Highlights:

• Over 80 countries participating

• More than 650 exhibitors

• Over 16,000 visitors expected

• Key sectors include functional raw materials and ingredients, OEM/ODM·Private Label, finished products, and services & technologies

• A professional exhibition to discover the latest products, trends, and business partners in the Asia-Pacific health functional food and nutraceutical market.
  By participating in Vitafoods Asia 2026, NeoCremar is identifying the latest global market trends and diverse functional ingredients while expanding engagement with international partners and clients.
  We will continue to strengthen our competitiveness in the functional ingredients sector and discover new business opportunities through ongoing R&D and global network expansion.
  Exhibition Name: Vitafoods Asia 2026
  Venue: Queen Sirikit National Convention Center (QSNCC), Bangkok, Thailand
  Dates: Wednesday, September 2 – Friday, September 4, 2026
  NeoCremar Booth: H1-D40

CPHI Korea is Korea's leading B2B exhibition connecting supply chains and businesses in the pharmaceutical, biotechnology, and healthcare industries.
The 2026 event will be held at COEX in Seoul from August 25 to 27, bringing together active pharmaceutical ingredient (API) manufacturers, biotech companies, CDMO/OEM providers, pharmaceutical equipment manufacturers, nutraceutical and functional food enterprises, as well as domestic and international buyers and decision-makers.

Key Highlights:

• Attendees from 80+ countries and regions

• 420+ exhibiting companies

• 12,000+ visitors

• Core sectors including APIs, biopharmaceuticals, CDMO, pharmaceutical equipment, and nutraceuticals/functional foods

Booth Location
C15

NeoCremar has initiated a preclinical study to validate the veterinary functional efficacy of its galacto-oligosaccharide ingredient, NeoGOS-P70.
This study, scheduled to run for approximately six months, will evaluate the potential of NeoGOS-P70 to improve gut health and skin barrier function in healthy companion dogs. The research will be conducted by Limpid Inc., a specialized veterinary clinical research organization, and will ensure scientific credibility through research advisory from the College of Veterinary Medicine at Seoul National University.
Through this study, NeoCremar aims to verify the potential application of NeoGOS-P70 in the companion animal sector and secure foundational data for future business expansion into the pet food and supplement markets. Furthermore, the company plans to pursue publication in international peer-reviewed journals based on the study findings.
We will continue to secure scientific evidence for our functional ingredients and expand the applicability of NeoGOS-P70 across diverse sectors.